biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by fatboy92on Oct 07, 2015 1:21pm

120 Views

Post# 24172094

RE:Interesting Statistic

Ha, and at the end wishing all honest BTI shareholders well. What a JOKE. Wishing us all well while obviously he is in such a poor mental health. Nobody's reading all of your posts. It's hard to read all the way through more than one or two . Your wasting your time. Or maybe you are being paid for your feeble attempts to get others bashers on your side. Soon we will have the news that we have been waiting for and there will be no place for you here without another name change and reversal of opinion. Good luck and say hello to your psychiatrist from all the honest BTI shareholders.

Bullboard Posts

Unique Battery Metals opportunity in Quebec